1-17 of 17
Petr Pavlíček
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Risk Groups in Relapsed and Refractory Multiple Myeloma Treated By Lenalidomide Based Triplets - Analysis of the Czech Myeloma Group

Jiri Minarik, Luděk Pour, Tomas Jelinek, Ivan Spicka, Alexandra Jungova, Jakub Radocha, Petr Pavlicek, Tomas Pika, Stork Martin, Jan Straub, Vojtech Latal, Dominik Fric, Vladimir Maisnar, Roman Hajek
Journal: Blood
Blood (2024) 144 (Supplement 1): 2378.
https://doi.org/10.1182/blood-2024-200014
Published: 2024
Journal Articles

A Multicenter Phase 2 Study Evaluating the Optimized Schedule of Belantamab Mafodotin 1.9 Mg/Kg Q8W Plus Bortezomib and Dexamethasone in Relapsed Refractory Multiple Myeloma

Tereza Popkova, Jakub Radocha, Martin Stork, Jiří Minařík, Jan Straub, Alexandra Jungova, Petr Pavlicek, Tomas Jelinek, Vladimir Maisnar, Ludek Pour, Tomas Pika, František Sedlák, Jan Soukup, Hana Plonkova, Ludmila Muronova, Viera Sandecka, Petra Krhovska, David Zihala, Roman Hajek
Journal: Blood
Blood (2024) 144 (Supplement 1): 1999.
https://doi.org/10.1182/blood-2024-211224
Published: 2024
Journal Articles

Comparison of Lenalidomide Based Triplets (IRD, KRD and DRD) in Relapsed and Refractory Multiple Myeloma in Routine Practice

Jiri Minarik, Ludek Pour, Tomas Jelinek, Ivan Spicka, Alexandra Jungova, Jakub Radocha, Petr Pavlicek, Tomas Pika, Martin Stork, Jan Straub, Vladimir Maisnar, Roman Hajek
Journal: Blood
Blood (2023) 142 (Supplement 1): 4733.
https://doi.org/10.1182/blood-2023-179299
Published: 2023
Journal Articles

Efficacy and Safety of Oral Ixazomib (Ixa), Intravenous (IV) Daratumumab (Dara), and IV/Oral Dexamethasone (Dex; IDd) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM) and 1-3 Prior Therapies: Results of the Final Analysis of a Phase 2 Study

Sosana Delimpasi, Meletios A. Dimopoulos, Jan Straub, Argiris Symeonidis, Roman Hájek, Cyrille Touzeau, Viralkumar K. Bhanderi, Jesus Berdeja, Petr Pavlíček, Jeffrey V. Matous, Pawel J. Robak, Kaveri Suryanarayan, Miguel Villareal, Dasha Cherepanov, Jaydeep K. Srimani, Huilan Yao, Richard Labotka, Robert Z. Orlowski
Journal: Blood
Blood (2022) 140 (Supplement 1): 9995–9997.
https://doi.org/10.1182/blood-2022-163092
Published: 2022
Journal Articles

Follow-up Analysis of Ixazomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in Routine Clinical Practice

Jiri Minarik, Jakub Radocha, Alexandra Jungova, Jan Straub, Tomas Jelinek, Tomas Pika, Ludek Pour, Petr Pavlicek, Lubica Harvanova, Lenka Capkova, Petra Krhovska, Katerina Machalkova, Pavel Jindra, Ivan Spicka, Hana Plonkova, Martin Stork, Martin Mistrik, Jaroslav Bacovsky, Vladimir Maisnar, Roman Hajek
Journal: Blood
Blood (2021) 138 (Supplement 1): 2716.
https://doi.org/10.1182/blood-2021-148836
Published: 2021
Journal Articles

Survival Analysis of Newly Diagnosed Transplant-Eligible Multiple Myeloma Patients in Czech Republic

Tereza Popkova, Ludek Pour, Ivan Spicka, Jakub Radocha, Alexandra Jungova, Jiri Minarik, Tomas Jelinek, Petr Pavlicek, Marta Krejci, Jan Straub, Vladimir Maisnar, Tereza Dekojova, Tomas Pika, Jan Soukup, Lenka Capkova, Roman Hájek
Journal: Blood
Blood (2021) 138 (Supplement 1): 4894.
https://doi.org/10.1182/blood-2021-153978
Published: 2021
Journal Articles

Overall Survival Benefit of Ixazomib, Lenalidomide and Dexamethasone (IRD) over Lenalidomide and Dexamethasone (RD) in RRMM Patients Treated in Routine Clinical Practice: Results from the Czech Registry of Monoclonal Gammopathies (RMG)

Jiri Minarik, MD PhD, Tomas Pika, MD PhD, Jakub Radocha, Alexandra Jungova, Jan Straub, MD, Tomas Jelinek, MD, Ludek Pour, MD, Petr Pavlicek, MD, Martin Mistrik, MD PhD, Lucie Brožová, MSc, Petra Krhovska, Katerina Machalkova, Pavel Jindra, MD PhD, Ivan Spicka, MD PhD Prof, Hana Plonkova, MD, Martin Stork, MD, Jaroslav Bacovsky, Lenka Capkova, Michal Sykora, Petr Kessler, MD, Lukáš Stejskal, MD, Adriana Heindorfer, Jana Ullrychova, Tomas Skacel, MD, Vladimir Maisnar, MD PhD MBA, Roman Hajek, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3139.
https://doi.org/10.1182/blood-2019-128865
Published: 2019
Journal Articles

Risk Factors Associated with Development of Extramedullary Disease in Multiple Myeloma

Martin Stork, MD, Sabina Sevcikova, PhD, Marta Krejci, Prof, MD PhD, Zdenek Adam, Prof. MD, Viera Sandecka, MD PhD, Vladimir Maisnar, MD TMD, MBA, Jakub Radocha, MD, Ivan Spicka, MD PhD Prof, Jan Straub, MD, Jiri Minarik, MD PhD, Tomas Pika, MD PhD, Alexandra Jungova, Evzen Gregora, MD, Petr Pavlicek, MD, David Vrabel, MSc, Jiri Jarkovsky, PhD, Lucie Brozova, MSc, Tomas Jelinek, MD, Roman Hajek, MD PhD, Ludek Pour, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5596.
https://doi.org/10.1182/blood-2018-99-114854
Published: 2018
Journal Articles

Treatment Outcomes of Real Life Elderly Multiple Myeloma Patients:Â Analysis from Registry of Monoclonal Gammopathies (RMG)

Jakub Radocha, MD, Roman Hajek, Lucie Brozova, MSc, Ludek Pour, MD, Ivan Spicka, MDPhDProf, Jiri Minarik, MD PhD, Evzen Gregora, MD, Alexandra Jungova, Jan Straub, MD, Tomas Jelinek, Tomas Pika, Petr Pavlicek, MD, Viera Sandecka, MDPhD, David Vrabel, MSc, Adriana Heindorfer, Martin Stork, MD, Michal Sykora, Vladimir Maisnar, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2019.
https://doi.org/10.1182/blood-2018-99-111882
Published: 2018
Journal Articles

Treatment of Relapsed and Refractory Multiple Myeloma with Fully Oral Triplet IRD (ixazomib, lenalidomide and dexamethasone) Is Safe and with Significant Therapeutic Outcomes

Jiri Minarik, MD PhD, Petra Krhovska, Tomas Jelinek, Alexandra Jungova, Martin Mistrik, MD PhD, Tomas Pika, MD PhD, Evzen Gregora, MD, Vladimir Maisnar, MD, Jan Straub, MD, Ludek Pour, MD, Lucie Brozova, MSc, Jaroslav Bacovsky, Hana Plonkova, Pavel Jindra, MD PhD, Petr Pavlicek, MD, Jakub Radocha, MD, Ivan Spicka, MDPhDProf, Martin Stork, MD, Vlastimil Scudla, Prof, MD CSc, Roman Hajek
Journal: Blood
Blood (2018) 132 (Supplement 1): 1959.
https://doi.org/10.1182/blood-2018-99-112046
Published: 2018
Journal Articles

Bortezomib-Based Induction Treatment for Patients with Multiple Myeloma Ineligible for Autologous Stem Cell Transplantation: A Retrospective Multicenter Study in Czech Republic

Viera Sandecka, MD, Ludek Pour, Doc,MD PhD, Sabina Sevcikova, RNDr, PhD, Lucie Brozova, MSc, Jan Straub, MD, Vlastimil Scudla, Prof, MD CSc, Vladimir Maisnar, Prof, MD PhD, Petr Pavlicek, MD, Zdenek Adam, Prof, MD CSc, Marta Krejci, Prof, MD PhD, Martin Stork, MD, Tomas Jelinek, Hana Plonkova, Roman Hajek
Journal: Blood
Blood (2017) 130 (Supplement 1): 5435.
https://doi.org/10.1182/blood.V130.Suppl_1.5435.5435
Published: 2017
Journal Articles

Multiple Myeloma R-ISS Prognostic Stratification System in Real Life Population

Jakub Radocha, MD PhD, Vladimír Maisnar, MD PhD, Ludek Pour, MD PhD, Zdenek Adam, MD PhD, Ivan Spicka, MD PhD, Jan Straub, MD, Vlastimil Scudla, prof, MD PhD, Jiri Minarik, MD PhD, Evzen Gregora, MD, Petr Pavlicek, MD, Hana Frankova, MD, Lenka Zahradova, MD PhD, Alexandra Jungova, MD, Michal Sykora, MD, Petr Kessler, MD, Dagmar Adamova, MD, Marek Wrobel, MD, Lenka Sedlarikova, MSc, Sabina Sevcikova, RNDr, PhD, Daniel Horinek, Ing, Jana Pelcova, MSc, Jiri Jarkovsky, MSc, PhD, Roman Hájek
Journal: Blood
Blood (2016) 128 (22): 3333.
https://doi.org/10.1182/blood.V128.22.3333.3333
Published: 2016
Journal Articles

Subcutaneous and Intravenous Bortezomib in Multiple Myeloma Patients Has Similar Response Rates and Toxicity Profile with No Difference in the Incidence of Peripheral Neuropathy: Report of the Czech Myeloma Group

Jiri Minarik, MD PhD, Petr Pavlicek, MD, Ludek Pour, Doc, MD PhD, Tomas Pika, MD PhD, Vladimir Maisnar, As Prof, MD PhD, Ivan Spicka, prof, MD PhD, Jiri Jarkovsky, RNDr, PhD, Marta Krejci, As Prof, MD PhD, Jaroslav Bacovsky, MD PhD, Jakub Radocha, MD PhD, Jan Straub, MD, Petr Kessler, MD, Marek Wrobel, MD, Lenka Walterova, MD, Michal Sykora, MD, Jarmila Obernauerova, MD, Evzen Gregora, MD, Dagmar Adamova, MD, Jaromir Gumulec, MD, Zdenek Adam, prof, MD PhD, Vlastimil Scudla, prof, MD PhD, Roman Hajek, Prof, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2117.
https://doi.org/10.1182/blood.V124.21.2117.2117
Published: 2014
Journal Articles

High-Dose Therapy and Autologous Stem Cell Transplantation for Multiple Myeloma: Analysis from Registry of Monoclonal Gammopathy of Czech Myeloma Group

Roman Hajek, Prof. MD, PhD, Ivan Spicka, As. Prof. MD, PhD, Vladimir Maisnar, As. Prof. MD, PhD, Tomas Pika, MD, PhD, Evzen Gregora, MD, Lenka Zahradova, MD, PhD, Jan Straub, MD, Jakub Radocha, MD, PhD, Jiri Minarik, MD, PhD, Petr Pavlicek, MD, Marta Krejci, As. Prof. MD, PhD, Ludek Pour, MD, PhD, Zdenek Adam, Prof. MD, PhD, Vlastimil Scudla, Prof. MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4528.
https://doi.org/10.1182/blood.V120.21.4528.4528
Published: 2012
Journal Articles

Bortezomib (Velcade) in the Treatment of Relapsed or Refractory Multiple Myeloma: Analysis of Safety and Efficacy of Bortezomib From Registry of Monoclonal Gammopathy of Czech Myeloma Group

Viera Sandecka, MD, Ivan Spicka, As. Prof. MD, PhD, Vladimir Maisnar, As. Prof. MD, PhD, Tomas Pika, MD, PhD, Evzen Gregora, MD, David Starostka, MD, Lenka Walterova, MD, Jaromir Gumulec, MD, Dagmar Adamova, MD, Marek Wrobel, MD, Ivan Vonke, MD, Lenka Zahradova, MD, PhD, Jan Straub, MD, Jakub Radocha, MD, PhD, Jiri Minarik, MD, PhD, Petr Pavlicek, MD, Petr Kessler, MD, Ludek Pour, MD, PhD, Roman Hajek, Prof. MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1872.
https://doi.org/10.1182/blood.V120.21.1872.1872
Published: 2012
Journal Articles

The Reduced Intensity Cvd Regimen: A Good Option with Well Balanced Efficacy/Toxicity Ratio for Elderly Patients with Poor Status Performance

Roman Hajek, Lenka Zahradova, Evzen Gregora, Miroslava Schutzova, Vladimir Koza, Petr Pavlicek, Ludek Pour, Marta Krejci, Viera Sandecka, Andrea Krivanova, Mohammed Al Sahmani, Dana Kralova, Zdenek Adam
Journal: Blood
Blood (2008) 112 (11): 3699.
https://doi.org/10.1182/blood.V112.11.3699.3699
Published: 2008
Journal Articles

Consolidation Therapy Based on Conventional Chemotherapy and Corticoids Do Not Provide Therapeutic Advantage for Newly Diagnosed Patients after Autologous Transplantation.

Roman Hajek Prof, MD, Ivan Spicka, MD, PhD, Vlastimil Scudla, MD, Evzen Gregora, MD, Vladimir Maisnar, MD, PhD, Miroslava Schutzova, MD, Elena Tothova Prof, MD, Martin Mistrik, MD, PhD, Marta Krejci, MD, PhD, Jan Straub, MD, Jiri Minarik, MD, Jakub Radocha, MD, Vladimir Koza, MD, PhD, Petr Pavlicek, MD, Libuse Novosadova, MD, Hana Frankova, MD, Yvetta Stavarova, MD, Petr Kessler, MD, Lenka Walterova, MD, Jaromir Gumulec, MD, Adam Svobodnik, PhD, Dana Kralova, Zdenek Adam, MD
Journal: Blood
Blood (2007) 110 (11): 531.
https://doi.org/10.1182/blood.V110.11.531.531
Published: 2007